🔎 Trials Near Me

Home › Blood Cancers › NCT06472089

BMT-CARE: Psychosocial Intervention for Transplant Caregivers

Recruiting

Multimodal Psychosocial Intervention for Caregivers of Patients Undergoing Hematopoietic Stem Cell Transplantation

Who can join

Ages 18 and older · All sexes

Full eligibility criteria
Caregiver Inclusion Criteria:

* Adult caregivers (≥18 years) relative or friend of a patient identified as living with them or having in-person contact with them at least twice a week.
* Caregiver of a patient receiving allogeneic or autologous HCT for the treatment of cancer.
* Ability to read and respond to survey questions in English, Spanish or with minimal assistance from an interpreter.

Caregiver Exclusion Criteria:

* Caregivers of patients undergoing HCT for a benign hematologic condition or undergoing outpatient HCT.
* Caregivers with a major untreated psychiatric or cognitive condition which the treating oncology clinicians believes interferes with the capacity to provide informed consent.
* Caregivers of patients who have already undergone HCT within the past 5 years

Patient Inclusion Criteria:

* Adult patients (≥18 years) with a hematologic malignancy and planned admission for autologous or allogeneic HCT.
* Ability to respond to questions in English, Spanish, or with minimal assistance from an interpreter.

About the study

The goal of this study is to evaluate whether a psychological intervention (BMT-CARE) is effective at improving the quality of life in caregivers and patients treated with hematopoietic cell transplant compared to usual care, and to identify critical facilitators and barriers for BMT-CARE implementation and adoption.

What is being tested

Sponsor: Massachusetts General Hospital · Participants: 800 · Started: Jan 10, 2025

Contact the study team

Official record on ClinicalTrials.gov — NCT06472089

Locations in the U.S.

AlabamaUniversity of Alabama at Brimingham, Birmingham
FloridaMoffitt Cancer Center, Tampa
MassachusettsMassachusetts General Hospital Cancer Center, Boston

Conditions

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.